Dyreforsøg med analoge papillomavira indikerer imidlertid, at L1 VLP- vaccinernes effekt medieres af udviklingen af humoralt antistofrespons.
HPV only infects humans, but animal studies with analogous papillomaviruses suggest that the efficacy of LI VLP vaccines is mediated by the development of a humoral immune response.